603 related articles for article (PubMed ID: 21504839)
21. Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells.
Chen L; Chen D; Gong M; Na M; Li L; Wu H; Jiang L; Qian Y; Fang G; Xue X
Cancer Lett; 2009 Nov; 284(2):141-8. PubMed ID: 19447545
[TBL] [Abstract][Full Text] [Related]
22. Improved glioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses.
Hoffmann D; Meyer B; Wildner O
J Gene Med; 2007 Sep; 9(9):764-78. PubMed ID: 17640083
[TBL] [Abstract][Full Text] [Related]
23. Relaxin-expressing, fiber chimeric oncolytic adenovirus prolongs survival of tumor-bearing mice.
Ganesh S; Gonzalez Edick M; Idamakanti N; Abramova M; Vanroey M; Robinson M; Yun CO; Jooss K
Cancer Res; 2007 May; 67(9):4399-407. PubMed ID: 17483354
[TBL] [Abstract][Full Text] [Related]
24. Interferon-α enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma.
Wang CJ; Xiao CW; You TG; Zheng YX; Gao W; Zhou ZQ; Chen J; Xue XB; Fan J; Zhang H
Mol Cancer; 2012 May; 11():31. PubMed ID: 22569271
[TBL] [Abstract][Full Text] [Related]
25. Oncolytic adenovirus SG600-IL24 selectively kills hepatocellular carcinoma cell lines.
Xue XB; Xiao CW; Zhang H; Lu AG; Gao W; Zhou ZQ; Guo XL; Zhong MA; Yang Y; Wang CJ
World J Gastroenterol; 2010 Oct; 16(37):4677-84. PubMed ID: 20872968
[TBL] [Abstract][Full Text] [Related]
26. Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus.
Zhang Q; Chen G; Peng L; Wang X; Yang Y; Liu C; Shi W; Su C; Wu H; Liu X; Wu M; Qian Q
Clin Cancer Res; 2006 Nov; 12(21):6523-31. PubMed ID: 17085667
[TBL] [Abstract][Full Text] [Related]
27. Targeted Hsp70 expression combined with CIK-activated immune reconstruction synergistically exerts antitumor efficacy in patient-derived hepatocellular carcinoma xenograft mouse models.
Hu H; Qiu Y; Guo M; Huang Y; Fang L; Peng Z; Ji W; Xu Y; Shen S; Yan Y; Huang X; Zheng J; Su C
Oncotarget; 2015 Jan; 6(2):1079-89. PubMed ID: 25473902
[TBL] [Abstract][Full Text] [Related]
28. An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma.
Li X; Su Y; Sun B; Ji W; Peng Z; Xu Y; Wu M; Su C
Mol Cancer Ther; 2016 Jul; 15(7):1436-51. PubMed ID: 27196772
[TBL] [Abstract][Full Text] [Related]
29. A novel A33 promoter-based conditionally replicative adenovirus suppresses tumor growth and eradicates hepatic metastases in human colon cancer models.
Cafferata EG; Macció DR; Lopez MV; Viale DL; Carbone C; Mazzolini G; Podhajcer OL
Clin Cancer Res; 2009 May; 15(9):3037-49. PubMed ID: 19336523
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal Stem Cell-Mediated Delivery of an Oncolytic Adenovirus Enhances Antitumor Efficacy in Hepatocellular Carcinoma.
Yoon AR; Hong J; Li Y; Shin HC; Lee H; Kim HS; Yun CO
Cancer Res; 2019 Sep; 79(17):4503-4514. PubMed ID: 31289131
[TBL] [Abstract][Full Text] [Related]
31. ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis.
Yun CO; Kim E; Koo T; Kim H; Lee YS; Kim JH
Cancer Gene Ther; 2005 Jan; 12(1):61-71. PubMed ID: 15375379
[TBL] [Abstract][Full Text] [Related]
32. Combining high selectivity of replication via CXCR4 promoter with fiber chimerism for effective adenoviral oncolysis in breast cancer.
Stoff-Khalili MA; Rivera AA; Stoff A; Michael Mathis J; Rocconi RP; Matthews QL; Numnum MT; Herrmann I; Dall P; Eckhoff DE; Douglas JT; Siegal GP; Zhu ZB; Curiel DT
Int J Cancer; 2007 Feb; 120(4):935-41. PubMed ID: 17131341
[TBL] [Abstract][Full Text] [Related]
33. Gene-viro-therapy targeting liver cancer by a dual-regulated oncolytic adenoviral vector harboring IL-24 and TRAIL.
Liu X; Cao X; Wei R; Cai Y; Li H; Gui J; Zhong D; Liu XY; Huang K
Cancer Gene Ther; 2012 Jan; 19(1):49-57. PubMed ID: 21979578
[TBL] [Abstract][Full Text] [Related]
34. Recombinant Adenovirus Expressing a Soluble Fusion Protein PD-1/CD137L Subverts the Suppression of CD8
Zhang Y; Zhang H; Wei M; Mou T; Shi T; Ma Y; Cai X; Li Y; Dong J; Wei J
Mol Ther; 2019 Nov; 27(11):1906-1918. PubMed ID: 31466933
[TBL] [Abstract][Full Text] [Related]
35. Modification of the early gene enhancer-promoter improves the oncolytic potency of adenovirus 11.
Wong HH; Jiang G; Gangeswaran R; Wang P; Wang J; Yuan M; Wang H; Bhakta V; Müller H; Lemoine NR; Wang Y
Mol Ther; 2012 Feb; 20(2):306-16. PubMed ID: 22086234
[TBL] [Abstract][Full Text] [Related]
36. A novel Ad5/11 chimeric oncolytic adenovirus for improved glioma therapy.
Li X; Mao Q; Wang D; Xia H
Int J Oncol; 2012 Dec; 41(6):2159-65. PubMed ID: 23117867
[TBL] [Abstract][Full Text] [Related]
37. Anticancer activity of oncolytic adenoviruses carrying p53 is augmented by 11R in gallbladder cancer cell lines in vitro and in vivo.
Wang J; Yu Y; Yan Z; Hu Z; Li L; Li J; Jiang X; Qian Q
Oncol Rep; 2013 Aug; 30(2):833-41. PubMed ID: 23727990
[TBL] [Abstract][Full Text] [Related]
38. Significant antitumor activity of oncolytic adenovirus expressing human interferon-beta for hepatocellular carcinoma.
He LF; Gu JF; Tang WH; Fan JK; Wei N; Zou WG; Zhang YH; Zhao LL; Liu XY
J Gene Med; 2008 Sep; 10(9):983-92. PubMed ID: 18618506
[TBL] [Abstract][Full Text] [Related]
39. An oncolytic adenovirus delivering TSLC1 inhibits Wnt signaling pathway and tumor growth in SMMC-7721 xenograft mice model.
Wang Y; Huang P; Hu Y; Guo K; Jia X; Huang B; Liu X; He X; Huang F
Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):766-774. PubMed ID: 33928346
[TBL] [Abstract][Full Text] [Related]
40. E1B 55-kDa deleted, Ad5/F35 fiber chimeric adenovirus, a potential oncolytic agent for B-lymphocytic malignancies.
Wang G; Li G; Liu H; Yang C; Yang X; Jin J; Liu X; Qian Q; Qian W
J Gene Med; 2009 Jun; 11(6):477-85. PubMed ID: 19340843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
